Literature DB >> 3525398

Preferential secretion of a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by normal mononuclear cells following stimulation with Klebsiella pneumoniae.

A el-Roiey, W L Gross, J Luedemann, D A Isenberg, Y Shoenfeld.   

Abstract

Peripheral blood mononuclear cells derived from 6 normal subjects were incubated with 5 polyclonal activators (pokeweed mitogen, Epstein-Barr virus, group-A Streptococcus, Staphylococcus aureus and Klebsiella pneumoniae. After 7 days of incubation, the supernatants were examined for immunoglobulin (IgG and IgM) production, the level of a common anti-DNA idiotype (16/6 Id) and autoantibody activity against ssDNA, dsDNA, poly(I), poly(dT) and cardiolipin. Significantly increased levels of the 16/6 Id were recorded only with the Klebsiella stimulated MNC. Increased immunoglobulin levels and autoantibody reactivity were noted with all 5 polyclonal activators. The Klebsiella cell membrane preparation induced the highest values. No correlation was found between the 16/6 levels, autoantibody activity and the absolute concentrations of IgG or IgM. This study, together with previous reports, suggests a role for Klebsiella in the etiology of autoimmune diseases. We suggest that Klebsiella can induce anti-DNA-like autoantibodies not only by polyclonal activation, but also by a more specific stimulus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525398     DOI: 10.1016/0165-2478(86)90036-2

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  12 in total

Review 1.  Autoantibodies and antibacterial antibodies: from both sides now.

Authors:  R A Watts; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 2.  Polyclonal B-cell activation by bacteria that induce nonsuppurative sequelae.

Authors:  W L Gross
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Anti-Klebsiella K30 phospholipid antibodies in systemic lupus erythematosus: antigen cross-reactions and idiotypic sharing with antibodies to DNA and Klebsiella K30 polysaccharide.

Authors:  G D Harkiss; F M Hendrie; D Thompson
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

4.  Expression of an interspecies idiotype in sera of SLE patients and their first-degree relatives.

Authors:  H Dang; M Takei; D Isenberg; Y Shoenfeld; R Backimer; J Rauch; N Talal
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  The sera of patients with Klebsiella infections contain a common anti-DNA idiotype (16/6) Id and anti-polynucleotide activity.

Authors:  A el-Roiey; O Sela; D A Isenberg; R Feldman; B C Colaco; R C Kennedy; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

6.  Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains.

Authors:  G J Silverman; A H Lucas
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

7.  Idiotype specific T-cell lines inducing experimental systemic lupus erythematosus in mice.

Authors:  H Fricke; S Mendlovic; M Blank; Y Shoenfeld; M Ben-Bassat; E Mozes
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

8.  Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells.

Authors:  E Cairns; H Massicotte; D A Bell
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

9.  Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti-cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family.

Authors:  M M Newkirk; H Gram; G F Heinrich; L Ostberg; J D Capra; R L Wasserman
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

Review 10.  SLE and infections.

Authors:  Gisele Zandman-Goddard; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.